Classic Galactosemia

Overview

Plain-Language Overview

Classic Galactosemia is a rare inherited disorder that affects how the body processes a sugar called galactose, which is found in milk and dairy products. This condition primarily impacts the liver, brain, and kidneys because the body cannot properly break down galactose due to a missing or faulty enzyme. As a result, harmful substances build up in the body, leading to serious health problems such as jaundice, vomiting, and failure to thrive in newborns. If untreated, it can cause long-term complications including intellectual disability and liver damage. Early diagnosis and dietary management are crucial to prevent these severe effects.

Clinical Definition

Classic Galactosemia is an autosomal recessive metabolic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridylyltransferase (GALT), which is essential for the proper metabolism of galactose. This enzyme deficiency leads to the accumulation of toxic metabolites such as galactose-1-phosphate and galactitol in tissues, causing cellular damage. The disorder typically presents in the neonatal period with symptoms including jaundice, hepatomegaly, cataracts, and sepsis often due to Escherichia coli infection. The underlying genetic defect is usually mutations in the GALT gene. The clinical significance lies in the potential for rapid progression to life-threatening complications if galactose intake is not restricted. Long-term complications include cognitive impairment, speech defects, and ovarian failure in females.

Inciting Event

Introduction of galactose-containing milk or formula triggers symptom onset.
Exposure to lactose in breast milk or cow’s milk formula initiates toxic metabolite accumulation.
Failure to metabolize galactose after birth leads to rapid clinical deterioration.

Latency Period

Symptoms typically develop within the first 1 to 3 weeks of life after milk feeding begins.
Clinical signs appear rapidly as toxic metabolites accumulate in tissues.
Delay in symptom onset beyond neonatal period is uncommon in classic galactosemia.

Diagnostic Delay

Early symptoms such as jaundice and vomiting are nonspecific and often attributed to common neonatal conditions.
Lack of routine newborn screening in some areas delays diagnosis.
Misdiagnosis as sepsis or other metabolic disorders due to overlapping clinical features.
Failure to recognize the significance of feeding intolerance and hepatomegaly in neonates.

Clinical Presentation

Signs & Symptoms

Vomiting and diarrhea shortly after milk ingestion
Jaundice and hepatomegaly in the neonatal period
Cataracts developing within the first few weeks of life
Lethargy and hypotonia indicating central nervous system involvement
Sepsis-like symptoms due to increased susceptibility to infections

History of Present Illness

Onset of poor feeding, vomiting, and lethargy within days to weeks after starting milk feeding.
Development of jaundice, hepatomegaly, and failure to thrive in the neonatal period.
Possible progression to sepsis-like syndrome with hypoglycemia and coagulopathy.
Infants may exhibit cataracts and hypotonia as disease progresses without treatment.

Past Medical History

Typically no prior medical history as symptoms begin in the neonatal period.
Absence of prior illnesses but history of feeding with lactose-containing formula or breast milk is critical.
No history of metabolic disorders unless previously diagnosed in siblings.

Family History

Presence of siblings with similar neonatal illness or early death suggests autosomal recessive inheritance.
Known family history of classic galactosemia or carrier status in parents.
Consanguinity or ethnic background with higher prevalence increases suspicion.

Physical Exam Findings

Jaundice with scleral icterus due to hepatic dysfunction
Hepatomegaly from liver inflammation and damage
Cataracts visible on slit-lamp examination in infants
Failure to thrive with poor weight gain and growth retardation
Hypotonia and developmental delay in untreated cases

Diagnostic Workup

Diagnostic Criteria

Diagnosis of galactosemia is established by measuring GALT enzyme activity in red blood cells, which is markedly reduced or absent in affected individuals. Newborn screening programs often detect elevated galactose or galactose-1-phosphate levels in blood. Confirmatory diagnosis includes molecular genetic testing for mutations in the GALT gene. Additional supportive findings include elevated galactose metabolites in urine and clinical features such as jaundice and feeding intolerance in the neonatal period.

Pathophysiology

Key Mechanisms

Deficiency of galactose-1-phosphate uridyltransferase (GALT) enzyme leads to toxic accumulation of galactose-1-phosphate in tissues.
Accumulation of galactitol via aldose reductase causes osmotic damage in lens and other tissues.
Impaired galactose metabolism disrupts energy production and cellular function in liver, brain, and kidneys.
Toxic metabolites cause hepatocellular injury, leading to jaundice and hepatomegaly.
Accumulation of galactose metabolites in the brain contributes to intellectual disability and neurologic deficits.

Involvement	Details
Organs	Liver is the primary organ affected, showing hepatomegaly, jaundice, and potential liver failure.
	Eyes develop cataracts due to galactitol accumulation in the lens.
	Brain involvement leads to intellectual disability and motor dysfunction in untreated patients.
Tissues	Liver tissue is damaged by toxic metabolite accumulation leading to hepatomegaly, jaundice, and fibrosis.
	Lens tissue undergoes osmotic swelling and damage resulting in cataracts.
	Brain tissue may show developmental abnormalities and neuronal loss contributing to cognitive impairment.
Cells	Hepatocytes are critically affected due to accumulation of toxic galactose-1-phosphate causing liver dysfunction.
	Lens epithelial cells accumulate galactitol leading to osmotic damage and formation of cataracts.
	Neurons may be damaged by toxic metabolites contributing to long-term neurological deficits.
Chemical Mediators	Galactose-1-phosphate accumulates due to deficient galactose-1-phosphate uridyltransferase activity, causing cellular toxicity.
	Galactitol accumulates in the lens, causing osmotic stress and cataract formation.
	UDP-galactose deficiency disrupts glycoprotein and glycolipid synthesis affecting multiple tissues.

Treatments

Pharmacological Treatments

Non-pharmacological Treatments

Strict lifelong dietary restriction of galactose and lactose to prevent toxic metabolite accumulation.
Supportive management of complications such as cataracts and liver dysfunction with appropriate specialist care.
Regular monitoring of growth, development, and neurological status to guide supportive interventions.

Prevention

Pharmacological Prevention

No established pharmacological prophylaxis exists for classic galactosemia
Management focuses on enzyme replacement or gene therapy under investigation but not standard
Supportive treatment with vitamin and mineral supplementation may be used to address deficiencies

Non-pharmacological Prevention

Newborn screening for early detection of GALT deficiency
Strict dietary restriction of galactose and lactose-containing foods
Avoidance of breast milk and cow's milk-based formulas
Genetic counseling for families with known GALT mutations
Regular monitoring of growth, development, and organ function to prevent complications

Outcome & Complications

Complications

Liver failure from progressive hepatic damage
Sepsis due to impaired immune function
Cataract formation causing visual impairment
Neurological impairment including intellectual disability and ataxia
Premature ovarian failure leading to infertility in females

Short-term Sequelae	Long-term Sequelae
Acute liver dysfunction with jaundice and coagulopathy Hypoglycemia due to impaired gluconeogenesis Sepsis and systemic infection in the neonatal period Electrolyte imbalances from vomiting and diarrhea Feeding intolerance and failure to thrive	Cognitive impairment and learning disabilities despite dietary management Speech and motor developmental delays Premature ovarian insufficiency causing infertility in females Osteopenia or osteoporosis due to chronic metabolic effects Chronic neurological symptoms such as tremor and ataxia

Differential Diagnoses

Classic Galactosemia versus Hereditary Fructose Intolerance

Classic Galactosemia	Hereditary Fructose Intolerance
Symptoms triggered by ingestion of galactose or lactose-containing foods	Symptoms triggered by ingestion of fructose, sucrose, or sorbitol
Elevated galactose-1-phosphate in erythrocytes and tissues	Elevated fructose-1-phosphate in liver and blood
Deficiency of galactose-1-phosphate uridyltransferase (GALT) enzyme activity or GALT gene mutation	Deficiency of aldolase B enzyme activity in liver biopsy or genetic testing

Classic Galactosemia versus Neonatal Sepsis

Classic Galactosemia	Neonatal Sepsis
Symptoms develop after introduction of galactose-containing feeds, typically within first weeks	Symptoms often present within the first few days of life with rapid progression
Negative blood cultures with metabolic abnormalities such as elevated galactose-1-phosphate	Positive blood cultures and elevated inflammatory markers (e.g., CRP, procalcitonin)
Improvement with galactose-restricted diet	Improvement with broad-spectrum antibiotics

Classic Galactosemia versus Galactokinase Deficiency

Classic Galactosemia	Galactokinase Deficiency
Elevated galactose-1-phosphate with normal or mildly elevated galactitol	Elevated galactitol in blood and urine without accumulation of galactose-1-phosphate
Liver failure, jaundice, and sepsis-like symptoms in addition to cataracts	Isolated cataracts without liver dysfunction or severe systemic symptoms
Deficiency of GALT enzyme activity	Deficiency of galactokinase enzyme activity

Classic Galactosemia versus Tyrosinemia Type I

Classic Galactosemia	Tyrosinemia Type I
Elevated galactose-1-phosphate and galactitol without succinylacetone	Elevated succinylacetone and tyrosine levels in blood and urine
Jaundice, hepatomegaly, and sepsis-like symptoms without renal tubular defects	Renal tubular dysfunction and rickets along with liver failure
Deficiency of GALT enzyme activity	Deficiency of fumarylacetoacetate hydrolase (FAH) enzyme activity

Classic Galactosemia versus Crigler-Najjar Syndrome

Classic Galactosemia	Crigler-Najjar Syndrome
Elevated galactose-1-phosphate with mixed hyperbilirubinemia	Isolated unconjugated hyperbilirubinemia with normal galactose metabolites
Jaundice with liver dysfunction and sepsis-like symptoms	Severe jaundice and risk of kernicterus without liver failure or sepsis
Deficiency of GALT enzyme activity	Deficiency of UDP-glucuronosyltransferase (UGT1A1) enzyme activity